COMPANY PROFILE // THE 014 REPORT
OKYO Pharma Ltd
OKYO (Nasdaq)
Assembled from 2 government sources in 0.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.
OKYO Pharma Ltd is an SEC-registered company in biological products, (no diagnostic substances), based in London, United Kingdom; listed as OKYO (Nasdaq).[source] It has filed 86 documents with the SEC in the last 12 months; the latest is Form 6-K, filed 2026-11-12.[source] Its largest institutional holders on 13F filings are Woodline Partners LP, Stonepine Capital Management, LLC, Maven Securities LTD (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- Woodline Partners LP$5.5M
- Stonepine Capital Management, LLC$1.3M
- Maven Securities LTD$1.2M
- Balyasny Asset Management L.P.$871K
- Opaleye Management Inc.$563K
- UBS Group AG$83K
- XTX Topco Ltd$57K
- CHOREO, LLC$50K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- JACOB GARY S · Chief Development Officer (Director,Officer) · latest Form 3 2026-03-18 · filing · LinkedIn search
- CERRONE GABRIELE M · Director,10% owner · latest Form 3 2026-03-18 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001849296 | source |
| EIN | 00-0000000 | source |
| NY DOS IDpossible match | 6001489 | record |
| Business address (SEC) | 55 PARK LANE, LONDON, X0, W1K 1NA | source |
Does not exist in the records we hold: LEI, UEI, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
No dated renewal or filing deadline is held for this entity: no SAM registration, no LEI and no periodic filing schedule on record.
PEERS BY SIC CODE
Industry context
SIC 2836 (biological products, (no diagnostic substances)): 183 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- AMGEN INC · 123 SEC filings in 12 months · 1 flag · $507.4M federal (possible match)
- Vir Biotechnology, Inc. · 117 SEC filings in 12 months · 1 flag · $65.9M federal (possible match)
- Vericel Corp · 109 SEC filings in 12 months · 1 flag · $37.3M federal (possible match)
- Coherus Oncology, Inc. · 53 SEC filings in 12 months · 3 flags · $11.8M federal (possible match)
- BIO-TECHNE Corp · 77 SEC filings in 12 months · 1 flag · $6.6M federal (possible match)
- Twist Bioscience Corp · 337 SEC filings in 12 months · 2 flags · $5.9M federal (possible match)
- Adaptive Biotechnologies Corp · 185 SEC filings in 12 months · 1 flag · $1.9M federal (possible match)
- AGENUS INC · 82 SEC filings in 12 months · 3 flags · $613K federal (possible match)
- REPLIGEN CORP · 89 SEC filings in 12 months · 1 flag · $457K federal (possible match)
- Revolution Medicines, Inc. · 171 SEC filings in 12 months · 2 flags · $15K federal (possible match)
- RECURSION PHARMACEUTICALS, INC. · 174 SEC filings in 12 months · 1 flag
- GILEAD SCIENCES, INC. · 173 SEC filings in 12 months
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-12 filing 6-K · SEC EDGAR
- 2026-11-05 filing 6-K · SEC EDGAR
- 2026-10-06 filing 6-K · SEC EDGAR
- 2026-09-29 filing 6-K · SEC EDGAR
- 2026-09-09 filing 6-K · SEC EDGAR
- 2026-09-08 filing 6-K · SEC EDGAR
- 2026-08-07 filing 20-F/A · SEC EDGAR
- 2026-07-28 filing 6-K · SEC EDGAR
- 2026-07-27 filing 6-K · SEC EDGAR
- 2026-07-23 filing 6-K · SEC EDGAR
- 2026-07-23 filing 6-K · SEC EDGAR
- 2026-07-22 filing 6-K · SEC EDGAR
- 2026-07-22 filing 6-K · SEC EDGAR
- 2026-07-22 filing 6-K · SEC EDGAR
- 2026-07-21 filing 6-K · SEC EDGAR
- 2026-07-21 filing 6-K · SEC EDGAR
- 2026-07-20 filing 6-K · SEC EDGAR
- 2026-07-20 filing Annual report (20-F) · SEC EDGAR
- 2026-07-08 filing 6-K · SEC EDGAR
- 2026-07-07 filing 6-K · SEC EDGAR
- 2026-05-19 filing 6-K · SEC EDGAR
- 2026-04-29 filing 6-K · SEC EDGAR
- 2026-04-07 filing 6-K · SEC EDGAR
- 2026-03-19 filing 6-K · SEC EDGAR
- 2026-03-19 filing 6-K · SEC EDGAR
- 2026-03-19 filing 6-K · SEC EDGAR
- 2026-03-18 filing 6-K · SEC EDGAR
- 2026-03-18 insider First Form 3/4/5 on record for JACOB GARY S (Chief Development Officer) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for CERRONE GABRIELE M (Director,10% owner) · SEC Forms 3/4/5
- 2026-03-12 filing 6-K · SEC EDGAR
170 earlier entries
- 2026-02-23 filing 6-K
- 2026-02-17 filing 424B5
- 2026-02-13 filing 6-K
- 2026-02-13 filing 6-K
- 2026-02-12 filing 6-K
- 2026-02-12 filing 424B5
- 2026-02-11 filing 6-K
- 2026-02-11 filing 6-K
- 2026-02-11 filing 424B5
- 2026-02-10 filing EFFECT
- 2026-02-10 filing 6-K
- 2026-02-06 filing UPLOAD
- 2026-02-06 filing CORRESP
- 2026-02-02 filing F-3
- 2026-01-30 filing 6-K
- 2026-01-30 filing 6-K
- 2026-01-28 filing 6-K
- 2026-01-23 filing 6-K
- 2026-01-05 filing 6-K
- 2025-12-19 filing 6-K
- 2025-12-15 filing 6-K
- 2025-12-11 filing 6-K
- 2025-12-03 filing 6-K
- 2025-11-21 filing 6-K
- 2025-11-18 filing 6-K
- 2025-10-29 filing 6-K
- 2025-10-16 filing 6-K
- 2025-09-22 filing 6-K
- 2025-08-12 filing 20-F/A
- 2025-07-18 filing Annual report (20-F)
- 2025-07-17 filing 6-K
- 2025-07-16 filing 6-K
- 2025-06-11 filing 6-K
- 2025-06-11 filing 424B5
- 2025-05-19 filing 6-K
- 2025-05-01 filing 6-K
- 2025-04-30 filing 6-K
- 2025-03-31 filing 6-K
- 2025-03-10 filing 6-K
- 2025-02-12 filing 6-K
- 2025-01-31 filing 6-K
- 2025-01-29 filing 6-K
- 2025-01-22 filing 6-K
- 2024-11-26 filing 6-K
- 2024-10-30 filing 6-K
- 2024-10-23 filing 6-K
- 2024-10-16 filing 6-K
- 2024-09-10 filing 6-K
- 2024-09-05 filing 6-K
- 2024-08-27 filing 6-K
- 2024-08-23 filing 6-K
- 2024-08-23 filing 6-K
- 2024-08-21 filing 6-K
- 2024-08-15 filing 6-K
- 2024-08-13 filing Annual report (20-F)
- 2024-08-06 filing 6-K
- 2024-07-31 filing NT 20-F
- 2024-07-11 filing 6-K
- 2024-07-10 filing 6-K
- 2024-07-10 filing 6-K
- 2024-05-08 filing 6-K
- 2024-04-30 filing 6-K
- 2024-04-09 filing 6-K
- 2024-04-04 filing 6-K
- 2024-04-02 filing 6-K
- 2024-03-29 filing 6-K
- 2024-03-22 filing 6-K
- 2024-03-21 filing 6-K
- 2024-03-20 filing 6-K
- 2024-02-09 filing 6-K
- 2024-01-31 filing 6-K
- 2024-01-08 filing 6-K
- 2024-01-05 filing 6-K
- 2023-12-21 filing 6-K
- 2023-12-20 filing 424B5
- 2023-12-18 filing 6-K
- 2023-12-18 filing 424B5
- 2023-12-04 filing 6-K
- 2023-11-29 filing 6-K
- 2023-11-01 filing 6-K
- 2023-10-31 filing 424B5
- 2023-10-31 filing 6-K
- 2023-10-10 filing 6-K
- 2023-10-05 filing 6-K
- 2023-09-15 filing 6-K
- 2023-09-15 filing 6-K
- 2023-09-15 filing 424B5
- 2023-09-14 filing 6-K
- 2023-09-14 filing 6-K
- 2023-09-13 filing 424B5
- 2023-09-13 filing 6-K
- 2023-09-08 filing 6-K
- 2023-08-30 filing 6-K
- 2023-08-29 filing 6-K
- 2023-08-25 filing 20-F/A
- 2023-08-15 filing 6-K
- 2023-08-15 filing Annual report (20-F)
- 2023-07-31 filing NT 20-F
- 2023-07-31 filing 6-K
- 2023-07-28 filing FWP
- 2023-07-28 filing 6-K
- 2023-07-28 filing 424B5
- 2023-07-28 filing 6-K
- 2023-07-28 filing 6-K
- 2023-07-27 filing 6-K
- 2023-06-15 filing 424B3
- 2023-06-14 filing EFFECT
- 2023-06-14 filing EFFECT
- 2023-06-12 filing CORRESP
- 2023-06-12 filing CORRESP
- 2023-06-12 filing UPLOAD
- 2023-06-09 filing F-1/A
- 2023-06-08 filing F-1/A
- 2023-06-08 filing F-3
- 2023-06-06 filing 6-K
- 2023-06-02 filing CORRESP
- 2023-06-02 filing F-1/A
- 2023-06-02 filing 8-A12B/A
- 2023-05-30 filing UPLOAD
- 2023-05-22 filing 6-K
- 2023-05-19 filing 6-K
- 2023-05-17 filing F-1
- 2023-05-15 filing 6-K
- 2023-05-11 filing 6-K
- 2023-05-11 filing 6-K
- 2023-05-03 filing 6-K
- 2023-05-03 filing 6-K
- 2023-05-03 filing 6-K
- 2023-05-02 filing 6-K
- 2023-04-25 filing 6-K
- 2023-04-05 filing 6-K
- 2023-04-04 filing 6-K
- 2023-03-30 filing 6-K
- 2023-03-29 filing 6-K
- 2023-03-24 filing 6-K
- 2023-03-16 filing 6-K
- 2023-03-15 filing 6-K
- 2023-03-15 filing 6-K
- 2023-03-14 filing 424B4
- 2023-03-14 filing 6-K
- 2023-03-13 filing 6-K
- 2023-03-08 filing EFFECT
- 2023-03-03 filing POS AM
- 2023-02-28 filing 6-K
- 2023-02-27 filing EFFECT
- 2023-02-23 filing CORRESP
- 2023-02-23 filing CORRESP
- 2023-02-23 filing 6-K
- 2023-02-22 filing F-1/A
- 2023-02-21 filing 6-K
- 2023-02-17 filing F-1/A
- 2023-02-14 filing 6-K
- 2023-01-19 filing FWP
- 2023-01-19 filing F-1/A
- 2023-01-17 filing CORRESP
- 2023-01-17 filing CORRESP
- 2023-01-17 filing CORRESP
- 2023-01-13 filing RW WD
- 2023-01-12 filing CORRESP
- 2023-01-12 filing RW
- 2023-01-10 filing CORRESP
- 2023-01-10 filing CORRESP
- 2023-01-05 filing CORRESP
- 2023-01-04 filing 6-K
- 2023-01-03 filing CORRESP
- 2023-01-03 filing CORRESP
- 2023-01-03 filing FWP
- 2023-01-03 filing F-1/A
- 2023-01-03 filing 6-K
- 2022-12-30 filing 6-K
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-12 (within 30 days) 6-K filed
- 2026-11-05 (within 30 days) 6-K filed
- 2026-10-06 (older) 6-K filed
- 2026-09-29 (older) 6-K filed
- 2026-09-09 (older) 6-K filed
- 2026-09-08 (older) 6-K filed
- 2026-08-07 (older) 20-F/A filed
- 2026-07-28 (older) 6-K filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-19; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:OKYO The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
2 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1849296 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | OKYO / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| CUSIP | G6724L116 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001849296 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Net income (loss) (fiscal year ended 2025-03-31) | -$4,706,292 | 2025-03-31 | 20-F, XBRL ProfitLoss | as filed | 2026-11-19 19:34 UTC | Report an error |
| Total assets (at 2025-03-31) | $3,677,336 | 2025-03-31 | 20-F, XBRL Assets | as filed | 2026-11-19 19:34 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | other | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-19 19:34 UTC | Report an error |
| SIC industry | 2836 Biological Products, (No Diagnostic Substances) | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-19 19:34 UTC | Report an error |
| Business address | 55 PARK LANE, LONDON, X0, W1K 1NA | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-19 19:34 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-19 19:34 UTC | Report an error |
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-12 Filing 6-K filed
- 2026-11-05 Filing 6-K filed
- 2026-10-06 Filing 6-K filed
- 2026-09-29 Filing 6-K filed
- 2026-09-09 Filing 6-K filed
- 2026-09-08 Filing 6-K filed
- 2026-08-07 Filing 20-F/A filed
- 2026-07-28 Filing 6-K filed
- 2026-07-27 Filing 6-K filed
- 2026-07-23 Filing 6-K filed
- 2026-07-23 Filing 6-K filed
- 2026-07-22 Filing 6-K filed
- 2026-07-22 Filing 6-K filed
- 2026-07-22 Filing 6-K filed
- 2026-07-21 Filing 6-K filed
- 2026-07-21 Filing 6-K filed
- 2026-07-20 Filing 6-K filed
- 2026-07-20 Filing 20-F filed
- 2026-07-08 Filing 6-K filed
- 2026-07-07 Filing 6-K filed
- 2026-05-19 Filing 6-K filed
- 2026-04-29 Filing 6-K filed
- 2026-04-07 Filing 6-K filed
- 2026-03-19 Filing 6-K filed
- 2026-03-19 Filing 6-K filed
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | Woodline Partners LP | $5,479,152 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:34 UTC | Report an error |
| 2 | Stonepine Capital Management, LLC | $1,294,494 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:34 UTC | Report an error |
| 3 | Maven Securities LTD | $1,213,976 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:34 UTC | Report an error |
| 4 | Balyasny Asset Management L.P. | $870,894 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:34 UTC | Report an error |
| 5 | Opaleye Management Inc. | $562,806 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:34 UTC | Report an error |
| 6 | UBS Group AG | $82,514 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:34 UTC | Report an error |
| 7 | XTX Topco Ltd | $56,654 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:34 UTC | Report an error |
| 8 | CHOREO, LLC | $49,883 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:34 UTC | Report an error |
| 9 | Quantinno Capital Management LP | $49,882 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:34 UTC | Report an error |
| 10 | Cerity Partners LLC | $19,218 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:34 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
2 state and city records carry this company's exact name, from 2 sources. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchOkyo Pharma Ltd · exact legal name · sx:ctgov:h2636a951559b6c2d Compare
New York corporations (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchOKYO PHARMA US INC. · name equals 'Okyo Pharma' but other unrelated entities share it · sx:nydos:6001489 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1849296.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001849296. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.